The identification of ACVR1 as the gene responsible for FOP and the studies aimed at investigating the molecular and cellular processes taking place in FOP pathophysiology have provided indications of several druggable targets suitable for the development of new therapeutic approaches for FOP. Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.